BioCentury
ARTICLE | Clinical News

DNAPrint preclinical data

December 18, 2006 8:00 AM UTC

In a mouse model of anemia, PT-401 was 3 times more effective than conventional erythropoietin (EPO) treatments. PT-401 is dimerized and genetically modified form of EPO. Data were presented at the Am...